Medtronic Insulin Pump Legal News Articles & Interviews

Tucson, AZ: Medtronic devices which have been around since 1988 and 1999 respectively have been the focus of much scrutiny in recent years, with the most recent concern landing earlier this year with a Class 1 recall related to software associated with the SynchroMed Implantable Infusion Pump. A Class 1 recall, about which anyone considering a Medtronic SynchroMed recall lawsuit would appreciate knowing, is the most serious of the three recall classifications maintained by the US Food and Drug Administration (FDA).

Washington, DC: While most Americans with type 1 or type 2 diabetes can control their condition with medication, those with more serious and debilitating forms of diabetes require constant monitoring, together with regular infusions of insulin to not only keep their blood glucose at appropriate levels, but to also keep them alive. Such functions, in recent years, have increasingly fallen within the purview of medical devices designed to monitor and infuse as needed, silently and automatically. However, the presence of a Medtronic lawsuit - two, in fact - suggests underlying problems that allegedly are costing people their lives.